EUVIMED · CrossrefJournal
The Lancet Regional Health - Western Pacific
ISSN 2666-6065 · Elsevier BV
Latest articles
A prospective cohort study of Streptococcus pyogenes sore throat among Australian children: preparation for future vaccine trials
Knee Care for Arthritis through Pharmacy Service (KneeCAPS) versus active control for knee osteoarthritis in Aotearoa New Zealand: a pragmatic community-based randomised controlled effectiveness trial
Validation and comparison of cardiovascular risk prediction models in Chinese patients with Chronic Kidney Disease: results from two population-based cohorts
Could Food is Medicine offer a healthcare-led pathway to improve nutrition and health equity in the Western Pacific?
Healthy schools, healthy children: planet-friendly school meals as a strategy for Healthy Pacific Islands
Short-, medium- and long-term sequelae following COVID-19 infection: a network cohort study across multiple Asia–Pacific regions
Policies, resource allocation, and interventions for substance use in the Pacific Island Countries/areas: a scoping review
Projected health, economic, and equity impacts of ad valorem, tier-based, and sugar content–based sugar-sweetened beverage tax policies in Thailand: a modelling study
A data-driven approach to tuberculosis screening of migrants entering Australia
Lessons from Cambodia: developing a national evidence-based policy and strategic plan for surgical, obstetric, and anaesthesia care
Effectiveness of prevention of mother-to-child transmission of hepatitis B virus and its associated factors among children born to HBsAg-positive mothers in China, 2023–2025: a nationwide cross-sectional study
Evaluation of the urine-based Fujifilm SILVAMP TB LAM II assay for diagnosis of pulmonary tuberculosis in facility-based and community-based settings in Vietnam: a multicentre diagnostic accuracy study
Inequalities in childhood full vaccination across 17 Asian low- and middle-income countries: a cross-sectional study, 2012–2023
Antimalarial treatment readiness during malaria elimination
Impact of extreme weather events on the dynamics of major notifiable infectious diseases in China, 2014–2022: a population-based study
Triple assessment with lipoprotein(a), high-sensitivity C-reactive protein and lipid profile stratified risk of major adverse cardiovascular events: 20-year follow-up of the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS)
Machine learning–based prediction of 30-, 60-, and 90-day postoperative mortality and major complications: an 11-year population-based cohort study in Hong Kong
How peptides are augmenting eating disorder risk
Natural-cause mortality among autistic individuals by age at autism diagnosis and sex: a population-based cohort study
Sex differences in treatment allocation and survival in hepatocellular carcinoma: a nationwide population-based cohort study
Corrigendum to “The burden of bacterial antimicrobial resistance in the WHO Western Pacific Region 1990–2021: a cross-country systematic analysis with forecasts to 2050” [The Lancet Regional Health – Western Pacific 2026; 75: 101997]
Associations of the cholesterol, high-density lipoprotein, and glucose (CHG) index with all-cause and cause-specific mortality: a population-based cohort study of 4 million Chinese adults
New Zealand's smoking decline and plateau: cautionary lessons for tobacco harm reduction
New Zealand's accelerating smoking decline: the evidence stands
Trends and transition dynamics of heated tobacco product use in Japan, 2015–2025: a repeated cross-sectional and longitudinal study
Trends and disparities in hepatitis B burden in the Western Pacific Region, 2015–2024: a subregional analysis using modelled data
Reimagining healthcare in Indonesia for 2045: a Lancet Regional Health – Western Pacific Commission
Effect of statins on the mortality of long-term survivors of nasopharyngeal carcinoma: a population-based study in endemic area
Burden of typhoid fever in primary and hospital care in Indonesia: a serial cross-sectional study using national health insurance (BPJS Kesehatan) data, 2015–2023
Tirofiban vs standard antiplatelet therapy in acute branch atheromatous disease-related stroke: a multicenter, randomized, open-label, blinded-endpoint, parallel-group, phase III clinical trial
EUVIMED